Table III.
Protein, ng/ml | CON (mean ± SD) | DOX (mean ± SD) | DOX+Val (mean ± SD) |
---|---|---|---|
Renin | 27.27±2.32 | 41.82±3.76a | 34.02±3.14a,b |
ALD | 246.55±68.03 | 376.87±85.34a | 264.25±71.05b |
MDA | 2.55±0.72 | 3.99±0.93a | 2.72±0.77b |
SOD | 144.61±32.15 | 105.48±22.65a | 138.84±18.16b |
ROS | 275.42±71.86 | 355.64±100.17a | 327.41±69.88b |
TNF-α | 173.52±20.88 | 260.24±23.47a | 211.77±20.59b |
IL-6 | 77.09±17.26 | 88.28±21.73a | 73.27±15.15b |
BNP | 208.31±33.62 | 331.77±22.45a | 275.73±26.21a,b |
NOX1 | 59.77±8.94 | 68.87±10.16a | 59.13±7.65b |
NOX2 | 44.22±9.55 | 51.41±7.31a | 49.21±3.80b |
NOX4 | 21.76±5.76 | 27.37±6.41a | 21.08±5.49b |
P<0.05 vs. CON group
P<0.05 vs. DOX group. CON, control; DOX, doxorubicin; Val, valsartan; NOX, NAD(P)H oxidase; SOD, superoxide dismutase; ROS, reactive oxygen species; BNP, brain natriuretic peptide; ALD, aldosterone; MDA, malondialdehyde.